APP下载

门冬胰岛素联合甘精胰岛素与门冬胰岛素30治疗2型糖尿病作用探讨

2018-10-18陈宏坤

糖尿病新世界 2018年7期
关键词:胰岛素血糖糖尿病

陈宏坤

[摘要] 目的 分析门冬胰岛素联合甘精胰岛素与门冬胰岛素30治疗2型糖尿病作用。方法 选取该院2014年6月—2017年7月期间收治32例2型糖尿病合并无症状脑梗死患者,分为观察和对照两组,每组16例。对照组治疗方法为门冬胰岛素30,观察组治疗方法为门冬胰岛素联合甘精胰岛素,比较两组患者临床疗效。结果 ①观察组治疗后FBG、2 hFBG以及HbAlc水平低于对照组,差异有统计学意义(P<0.05);观察组INS、TG、CHO、LDL-C水平均低于对照组,同时低血糖发生率显著降低,并且在随访中患者无再次发生脑梗死,差异有统计学意义(P<0.05)。 结论 门冬胰岛素联合甘精胰岛素对2型糖尿病患者进行治疗效果显著,降低低血糖发生率,充分预防及控制脑梗死的复发与再发。

[关键词] 门冬胰岛素;甘精胰岛素;2型糖尿病;脑梗死;临床效果

[中图分类号] R743 [文献标识码] A [文章编号] 1672-4062(2018)04(a)-0078-02

[Abstract] Objective To analyze the effect of insulin aspart combined with insulin glargine and insulin aspart 30 in treatment of type 2 diabetes. Methods 32 cases of patients with diabetes combined with silent brain infarction admitted and treated in our hospital from June 2014 to July 2017 were selected and divided into two groups with 16 cases in each, the control group were treated with insulin aspart 30, while the observation group were treated with insulin aspart combined with insulin glargine, and the clinical curative effect was compared between the two groups. Results After treatment, the FBG, 2Hfbg, HbAlc levels in the observation group were lower than those in the control group, and the differences between the two groups were statistically significant(P<0.05), and the INS, TG, CHO, LDL-C levels in the observation group were lower than those in the control group, and the incidence rate of hypoglycemia obviously decreased, and there were no second cerebral infraction in patients, and the difference was statistically significant(P<0.05). Conclusion The effect of insulin aspart combined with insulin glargine in treatment of type 2 diabetes is obvious, which can reduce the incidence rate of hypoglycemia, and fully prevent and control the recurrence and second recurrence of cerebral infraction.

[Key words] Insulin aspart; Insulin glargine; Type 2 diabetes; Cerebral infraction; Clinical effect

目前,糖尿病患病率逐年提升,并且患病人群趋于年轻化,并且易发生心脑血管等并发症,临床中常见因血糖未得到合理控制而出现脑血管病,成为患者致残的主要原因之一[1]。2014年6月—2017年7月期间该次研究主要分析门冬胰岛素联合甘精胰岛素与门冬胰岛素30治疗2型糖尿病作用效果,现报道如下。

1 资料与方法

1.1 一般资料

抽取该院收治的32例2型糖尿病合并无症状脑梗死患者,分为观察和对照两组,每组16例。对照组男性/女性为10/6,年龄跨度41~66岁,(56.3±1.7)岁为该组患者平均年龄,观察组男性/女性为11/5,年龄跨度43~68岁,(57.7±1.9)岁为该组患者平均年龄。

1.2 入选和排除标准

入选[2]:所有患者均符合WHO 2型糖尿病诊断标准内容;单纯选择门冬胰岛素30治疗且治疗时间大于3年,在头部CT或MRI有影像学改变但MRA无明显动脉病变且无临床症狀;空腹血糖在8.0 mmol/L以上,餐后2 h血糖在12 mmol/L以上。排除[3]:将患明显神经功能缺损患者予以排除;排除因其他疾病引发的2型糖尿病患者;……

登录APP查看全文

猜你喜欢

胰岛素血糖糖尿病
糖尿病知识问答
糖尿病知识问答
细嚼慢咽,对减肥和控血糖有用么
一吃饺子血糖就飙升,怎么办?
糖尿病知识问答
糖尿病知识问答
自己如何注射胰岛素
妊娠期血糖问题:轻视我后果严重!
猪的血糖与健康
门冬胰岛素30联合二甲双胍治疗老年初诊2型糖尿病疗效观察